|Prof. Dominique Belpomme|
NOTE (by Jean Hudon, Québec, http://www.cqlpe.ca/
): This paper — published on July 7 by an international group of 30 co-authors led by Dominique Belpomme and Philippe Irigaray — does NOT call for medicalization of electrohypersensitivity, (i.e. giving medication to treat the symptoms while ignoring the high environmental levels of EMF mechanisms that are causing the functional disability).
This paper simply states that this physical condition that patients are complaining of needs to be taken seriously by medical professionals and researched like any other medical or biological condition; and that it cannot be just "excused" as psychological or psychosomatic, based on faulty (and industry-funded) provocation studies.
The Critical Importance of Molecular Biomarkers and Imaging in the Study of Electrohypersensitivity. A Scientific Consensus International Report
by Dominique Belpomme, George L. Carlo, Philippe Irigaray, David O. Carpenter, Lennart Hardell, Michael Kundi, Igo Belyaev, Magda Havas, Franz Adlkofer, Gunnar Heuser, Anthony B. Miller, Daniela Caccamo, Chiara De Luca, Lebrecht von Klitzing, Martin L. Pall, Priyanka Bandara, Yael Stein, Cindy Sage, Morando Soffritti, Devra Davis, Joel M. Moscowitz, S.M.J. Mortazavi, Martha R. Herbert, Hanns Moshammer, Gerard Ledoigt, Robert Turner, Anthony Tweedale, Pilar Muñoz-Calero, Iris Udasin, Tarmo Keppel, Ernesto Burgio and André Vander Vorst
Int. J. Mol. Sci. 2021, 22(14), 7321; Published: 7 July 2021